Organ transplantation is the most common treatment in the event of near-total function loss in organs such as kidney, heart, and liver failure. Although there are alternative treatments in end-stage renal failure, kidney transplantation is the most accurate treatment in terms of quality of life, risks, and costs. A kidney transplant is the most common organ transplant.
Organs taken from people who lost their lives by the legal definition of death are taken from the body and placed in the body of the person in need of organs within the framework of legal rules.
The kidney is an organ that can be donated in terms of having two in the body. Only after the health of the kidney donor is checked and all risks are evaluated, it can be taken within the framework of legal rules.
Organ Transplant Types
- Kidney Transplant
- Liver Transplant
- Lung Transplant
- Heart transplant
- Skin transplant (face transplant)
- Cornea Transplant
- Limb (arm-leg) transplant
- Pancreas Transplant
- Trachea Transplant
- Vascular Tissue Transplantation
What are the risks of organ transplantation?
Since it is a surgical procedure, organs taken from a living donor may have health risks (pain, infection, bleeding, hernia, vascular occlusion, wound complications) as well as organ function and psychological problems in the short and long term. Since it is the procedure to protect the comfort of life, the risks for the organ recipient are very low. In the long-term follow-up, it was understood that the donors were in good health. Like organ donation anxiety, depression can cause mental health problems. Very rarely, the donated organ can be rejected by the recipient, and in these cases, rapid cortisone treatment can be successful. To minimize such situations, a donation should be made after a good evaluation of the appropriate donor.
Prevention, early diagnosis, and appropriate treatment of infectious diseases are the most important tools in reducing the need for organ transplantation. As a specialty, the development of Transplant Infectious Disease, more effective immunosuppressive drugs, more organ transplantation, and long-term survival of the given organ and the patient have been the main reasons.
Recent developments include international standards of quantitative molecular analyzes for common viruses, demonstrating the links between the risk of a specific infection and genetic polymorphisms in immune responses, and newer antimicrobial treatments, including those for hepatitis C virus (HCV), as well as some detailed application guidelines. Challenges include scarcity of analysis to assess the risk of specific infections or organ rejection, increased antimicrobial resistance, suboptimal screening paradigms for microbiological evaluation of organ donors, virus-associated malignancies, and changes in global infection patterns.